Literature DB >> 28533339

Structure-based prediction of Wnt binding affinities for Frizzled-type cysteine-rich domains.

Mark Agostino1,2, Sebastian Öther-Gee Pohl3, Arun Dharmarajan3.   

Abstract

Wnt signaling pathways are of significant interest in development and oncogenesis. The first step in these pathways typically involves the binding of a Wnt protein to the cysteine-rich domain (CRD) of a Frizzled receptor. Wnt-Frizzled interactions can be antagonized by secreted Frizzled-related proteins (SFRPs), which also contain a Frizzled-like CRD. The large number of Wnts, Frizzleds, and SFRPs, as well as the hydrophobic nature of Wnt, poses challenges to laboratory-based investigations of interactions involving Wnt. Here, utilizing structural knowledge of a representative Wnt-Frizzled CRD interaction, as well as experimentally determined binding affinities for a selection of Wnt-Frizzled CRD interactions, we generated homology models of Wnt-Frizzled CRD interactions and developed a quantitative structure-activity relationship for predicting their binding affinities. The derived model incorporates a small selection of terms derived from scoring functions used in protein-protein docking, as well as an energetic term considering the contribution made by the lipid of Wnt to the Wnt-Frizzled binding affinity. Validation with an external test set suggests that the model can accurately predict binding affinity for 75% of cases and that the error associated with the predictions is comparable with the experimental error. The model was applied to predict the binding affinities of the full range of mouse and human Wnt-Frizzled and Wnt-SFRP interactions, indicating trends in Wnt binding affinity for Frizzled and SFRP CRDs. The comprehensive predictions made in this study provide the basis for laboratory-based studies of previously unexplored Wnt-Frizzled and Wnt-SFRP interactions, which, in turn, may reveal further Wnt signaling pathways.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Frizzled receptor; Wnt signaling; cysteine-rich domain; homology modeling; lipid-protein interaction; protein-protein interaction; structural biology; structure-activity relationship

Mesh:

Substances:

Year:  2017        PMID: 28533339      PMCID: PMC5500790          DOI: 10.1074/jbc.M117.786269

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  92 in total

1.  Insights into protein-protein binding by binding free energy calculation and free energy decomposition for the Ras-Raf and Ras-RalGDS complexes.

Authors:  Holger Gohlke; Christina Kiel; David A Case
Journal:  J Mol Biol       Date:  2003-07-18       Impact factor: 5.469

2.  Automatic atom type and bond type perception in molecular mechanical calculations.

Authors:  Junmei Wang; Wei Wang; Peter A Kollman; David A Case
Journal:  J Mol Graph Model       Date:  2006-02-03       Impact factor: 2.518

3.  Systematic mapping of WNT-FZD protein interactions reveals functional selectivity by distinct WNT-FZD pairs.

Authors:  Jacomijn P Dijksterhuis; Bolormaa Baljinnyam; Karen Stanger; Hakki O Sercan; Yun Ji; Osler Andres; Jeffrey S Rubin; Rami N Hannoush; Gunnar Schulte
Journal:  J Biol Chem       Date:  2015-01-20       Impact factor: 5.157

Review 4.  Secreted and transmembrane wnt inhibitors and activators.

Authors:  Cristina-Maria Cruciat; Christof Niehrs
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-03-01       Impact factor: 10.005

5.  Crystal structures of the extracellular domain of LRP6 and its complex with DKK1.

Authors:  Zhihong Cheng; Travis Biechele; Zhiyi Wei; Seamus Morrone; Randall T Moon; Liguo Wang; Wenqing Xu
Journal:  Nat Struct Mol Biol       Date:  2011-10-09       Impact factor: 15.369

6.  CCharPPI web server: computational characterization of protein-protein interactions from structure.

Authors:  Iain H Moal; Brian Jiménez-García; Juan Fernández-Recio
Journal:  Bioinformatics       Date:  2014-09-02       Impact factor: 6.937

7.  Secreted frizzled-related protein 4: an angiogenesis inhibitor.

Authors:  Ajit Muley; Syamantak Majumder; Gopi Krishna Kolluru; Steve Parkinson; Helena Viola; Livia Hool; Frank Arfuso; Ruth Ganss; Arun Dharmarajan; Suvro Chatterjee
Journal:  Am J Pathol       Date:  2010-01-07       Impact factor: 4.307

8.  Targeting ROR1 inhibits epithelial-mesenchymal transition and metastasis.

Authors:  Bing Cui; Suping Zhang; Liguang Chen; Jianqiang Yu; George F Widhopf; Jessie-F Fecteau; Laura Z Rassenti; Thomas J Kipps
Journal:  Cancer Res       Date:  2013-06-15       Impact factor: 12.701

9.  SFRP-4 abrogates Wnt-3a-induced beta-catenin and Akt/PKB signalling and reverses a Wnt-3a-imposed inhibition of in vitro mammary differentiation.

Authors:  Thecla Constantinou; Fabrizio Baumann; Markus D Lacher; Susanne Saurer; Robert Friis; Arun Dharmarajan
Journal:  J Mol Signal       Date:  2008-05-02

10.  Frizzled-4 C-terminus Distal to KTXXXW Motif is Essential for Normal Dishevelled Recruitment and Norrin-stimulated Activation of Lef/Tcf-dependent Transcriptional Activation.

Authors:  Alexander C Bertalovitz; Milly S Pau; Shujuan Gao; Craig C Malbon; Hsien-Yu Wang
Journal:  J Mol Signal       Date:  2016-02-05
View more
  13 in total

1.  Structural and dynamic characterization of human Wnt2-Fzd7 complex using computational approaches.

Authors:  Hourieh Kalhor; Mansour Poorebrahim; Hamzeh Rahimi; Ali Akbar Shabani; Morteza Karimipoor; Mohammad Reza Akbari Eidgahi; Ladan Teimoori-Toolabi
Journal:  J Mol Model       Date:  2018-09-06       Impact factor: 1.810

2.  Fenretinide, Tocilizumab, and Reparixin Provide Multifaceted Disruption of Oral Squamous Cell Carcinoma Stem Cell Properties: Implications for Tertiary Chemoprevention.

Authors:  Susan R Mallery; Daren Wang; Brian Santiago; Ping Pei; Caroline Bissonnette; Jayanetti Asiri Jayawardena; Steven P Schwendeman; Richard Spinney; James Lang
Journal:  Mol Cancer Ther       Date:  2019-09-12       Impact factor: 6.261

Review 3.  Sfrp4 and the Biology of Cortical Bone.

Authors:  Ruiying Chen; Roland Baron; Francesca Gori
Journal:  Curr Osteoporos Rep       Date:  2022-02-19       Impact factor: 5.163

Review 4.  The Role of Wnt Signalling in Angiogenesis.

Authors:  Jun Jun Olsen; Sebastian Öther-Gee Pohl; Abhijeet Deshmukh; Malini Visweswaran; Natalie C Ward; Frank Arfuso; Mark Agostino; Arun Dharmarajan
Journal:  Clin Biochem Rev       Date:  2017-11

5.  GATA4 regulates mesenchymal stem cells via direct transcriptional regulation of the WNT signalosome.

Authors:  Aysha B Khalid; Jacquelyn Pence; Sarocha Suthon; Jianjian Lin; Gustavo A Miranda-Carboni; Susan A Krum
Journal:  Bone       Date:  2020-12-16       Impact factor: 4.398

Review 6.  Regulation of Wnt distribution and function by Drosophila glypicans.

Authors:  Indrayani Waghmare; Andrea Page-McCaw
Journal:  J Cell Sci       Date:  2022-02-03       Impact factor: 5.285

7.  In-depth characterization of the Wnt-signaling/β-catenin pathway in an in vitro model of Barrett's sequence.

Authors:  Katharina Götzel; Olga Chemnitzer; Luisa Maurer; Arne Dietrich; Uwe Eichfeld; Orestis Lyros; Yusef Moulla; Stefan Niebisch; Matthias Mehdorn; Boris Jansen-Winkeln; Michael Vieth; Albrecht Hoffmeister; Ines Gockel; René Thieme
Journal:  BMC Gastroenterol       Date:  2019-03-06       Impact factor: 3.067

8.  Wnt Binding Affinity Prediction for Putative Frizzled-Type Cysteine-Rich Domains.

Authors:  Mark Agostino; Sebastian Öther-Gee Pohl
Journal:  Int J Mol Sci       Date:  2019-08-26       Impact factor: 5.923

Review 9.  Sfrp5/Wnt Pathway: A Protective Regulatory System in Atherosclerotic Cardiovascular Disease.

Authors:  Shan Tong; Qingwei Ji; Yu Du; Xiaogang Zhu; Caizhong Zhu; Yujie Zhou
Journal:  J Interferon Cytokine Res       Date:  2019-06-13       Impact factor: 2.607

10.  Quantitative Profiling of WNT-3A Binding to All Human Frizzled Paralogues in HEK293 Cells by NanoBiT/BRET Assessments.

Authors:  Paweł Kozielewicz; Rawan Shekhani; Stefanie Moser; Carl-Fredrik Bowin; Janine Wesslowski; Gary Davidson; Gunnar Schulte
Journal:  ACS Pharmacol Transl Sci       Date:  2021-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.